Head to Head Contrast: Nutex Health (NASDAQ:NUTX) vs. Bausch + Lomb (NYSE:BLCO)

Bausch + Lomb (NYSE:BLCO) and Nutex Health (NASDAQ:NUTX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, analyst recommendations, profitability, earnings and risk.

Profitability

This table compares Bausch + Lomb and Nutex Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-7.06%	2.77%	1.31%
Nutex Health	7.34%	17.67%	7.37%

Analyst Ratings

This is a breakdown of current ratings for Bausch + Lomb and Nutex Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1	10	4	0	2.20
Nutex Health	0	1	2	0	2.67

Bausch + Lomb presently has a consensus price target of $18.25, indicating a potential upside of 16.27%. Nutex Health has a consensus price target of $252.50, indicating a potential upside of 183.74%. Given Nutex Health’s stronger consensus rating and higher possible upside, analysts clearly believe Nutex Health is more favorable than Bausch + Lomb.

Insider and Institutional Ownership

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 5.3% of Nutex Health shares are held by institutional investors. 0.8% of Bausch + Lomb shares are held by company insiders. Comparatively, 36.9% of Nutex Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Bausch + Lomb has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500.

Valuation and Earnings

This table compares Bausch + Lomb and Nutex Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10 billion	1.09	-$360.00 million	($1.02)	-15.39
Nutex Health	$875.26 million	0.71	$70.79 million	$8.98	9.91

Nutex Health has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Summary

Nutex Health beats Bausch + Lomb on 9 of the 14 factors compared between the two stocks.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.